Filter by patients with: All

What is MS Phase 2 Study ONO-4641?

Category: Others

false

See also: Clinical Trial

NCT01081782 is a a double-blind, placebo-controlled study of the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis. Other study names is ONO-4641POU006.

See patients taking MS Phase 2 Study ONO-4641

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Multiple sclerosis 1 1
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See 1 patient that have used MS Phase 2 Study ONO-4641

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with MS Phase 2 Study ONO-4641

Side effect Patients Percentage

Why patients stopped taking MS Phase 2 Study ONO-4641

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 1
Doctor's advice 1
See 1 patient who's stopped using MS Phase 2 Study ONO-4641

Duration

Stopped using MS Phase 2 Study ONO-4641

Duration Patients Percentage
6 months - 1 year 1
Adherence
Adherence Evaluations Percentage
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Last updated:
There are no evaluations for MS Phase 2 Study ONO-4641.